Back to Boston Partners Boston Partners

CDNACDNA
Showing 8 of 13 quarters

Position history for Boston PartnersBoston Partners's holdings in CareDx, Inc.

Boston Partners holds 1.9M shares of CDNA (CareDx, Inc.), worth $55.2M as of 2026-Q2. The position was increased (+2.9% shares). CDNA represents 0.0% of Boston Partners's portfolio.

Current Value

$55.2M

Current Shares

1.9M

Total Value Change

+$43.5M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+2.9%
$55.2M0.0%$28.50
30
2026-Q1
Increased
1.9M
+108.8%
$32.7M0.0%$18.80
47
2025-Q4
Increased
901,929
+2776.5%
$17M0.0%$19.07
46
2025-Q3
Increased
31,355
+45.9%
$455,9000.0%$14.86
33
2025-Q2
Increased
21,491
+0.2%
$419,9300.0%$19.23
24
2025-Q1
Increased
21,457
+0.7%
$380,8600.0%$17.96
24
2024-Q4
Decreased
21,299
-94.3%
$456,0100.0%$21.18
0
2024-Q3
Increased
375,138
+1444.5%
$11.7M0.0%$29.70
45

Other major holders of CDNA: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FRED ALGER MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used